Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.

Related Articles Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic. Oncology (Williston Park). 2020 08 12;34(8):317-319 Authors: Carril-Ajuria L, Remolina-Bonilla YA, Carretero-Gonzalez A, Martin-Soberon M, Castellano D, Bourlon C, de Velasco G, Bourlon MT Abstract A 78-year-old man had a medical history of hypertension, atrial fibrillation, chronic kidney disease, and metastatic castration-resistant prostate cancer (CRPC). He had progressed to first-line therapy for CRPC with abiraterone plus androgen-deprivation therapy (ADT) and as second-line therapy he was being treated with docetaxel, with biochemical progression in his last prostate specific antigen measurement. He was admitted to the hospital…
Origen: Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic. – PubMed